m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis
Epigenomes · 19.09.2025 · 9 (3) · 36
DOI: 10.3390/epigenomes9030036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epigenomes, online erschienen am 19.09.2025. Verfasst von Ambrose Loc Ngo und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine, Kansas City University, Farber-McIntire Campus, 2901 St. Johns Blvd, Joplin, MO 64804, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcoholism and Alcohol Abuse, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
N6-methyladenosine (m6A) is the most prevalent internal modification in eukaryotic messenger RNA (mRNA) and plays a vital role in post-transcriptional gene regulation. In recent years, m6A has emerged as a pivotal epitranscriptomic signal involved in neural development, synaptic remodeling, and the molecular pathophysiology of neuropsychiatric disorders. In this review, we summarize the mechanisms underlying the deposition, removal, and recognition of m6A by dedicated methyltransferases, demethylases, and RNA-binding proteins. We further explore how these dynamic modifications influence neuronal differentiation and memory formation. Recent studies have linked aberrant m6A regulation to psychiatric conditions such as depression, anxiety, schizophrenia, and bipolar disorder. Additionally, we discuss how pharmacological or genetic modulation of m6A pathways may promote adaptive neural plasticity and enhance cognitive and emotional resilience. Despite these promising findings, significant challenges remain in achieving spatial and temporal specificity while minimizing off-target effects in the brain. Therefore, we advocate for more in-depth investigations into m6A function within developmentally defined neural circuits to better understand its enduring role in maintaining neural homeostasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Osteopathic Medicine, Kansas City University, Farber-McIntire Campus, 2901 St. Johns Blvd, Joplin, MO 64804, USA.
- College of Pharmacy, Western University, California Campus, 309 E. Second St., Pomona, CA 91766-1854, USA.
- Department of Psychiatry, Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118-2526, USA.
- The Biomedical Genetics Section, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 East Concord Street, Boston, MA 02118-2526, USA.
ORCID-Profile: Huiping Zhang
Förderung
- NIAAA NIH HHS
- National Institute on Alcoholism and Alcohol Abuse
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Ngo, A. L., Nguyen, L., Gharavi Alkhansari, N., & Zhang, H. (2025). m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. Epigenomes, 9(3), 36. https://doi.org/10.3390/epigenomes9030036
Vancouver
Ngo AL, Nguyen L, Gharavi Alkhansari N, Zhang H. m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis. Epigenomes. 2025;9(3):36. doi:10.3390/epigenomes9030036
BibTeX
@article{Ngo2025,
author = {Ngo, Ambrose Loc and Nguyen, Linda and Gharavi Alkhansari, Niki and Zhang, Huiping},
title = {m6A RNA Methylation in Psychiatric Disorders: An Emerging Epitranscriptomic Axis},
journal = {Epigenomes},
year = {2025},
volume = {9},
number = {3},
pages = {36},
doi = {10.3390/epigenomes9030036}
}
EUVIMED